drug-development

Documents about drug-development

• Drug Discovery and Development#1205705Open Library
• Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)#1072637ClinicalTrials.gov
• Computational Approaches in Preclinical Studies on Drug Discovery and Development#335662OpenAlex
• Drug Repurposing for Rare Diseases#976506OpenAlex
• Zoliflodacin Bioequivalence and Drug-Drug Interaction Study#886715ClinicalTrials.gov
• Integrating artificial intelligence in drug discovery and early drug development: a transformative approach#381109OpenAlex
• Pharmacology, drug development & therapeutics#24627Wikidata
• The emerging roles of artificial intelligence in cancer drug development and precision therapy#421626OpenAlex
• Development of an adverse drug event network to predict drug toxicity#179438HAL (France)
• Drug Development Cost Increase Analysis#208047Zenodo (CERN)
• Study of Antiepileptic Drug Effects on Child Development#1485075ClinicalTrials.gov
• Principles of early drug discovery#6669OpenAlex
• Cognitive Task Development and Implementation for Functional MRI Studies#899437ClinicalTrials.gov
• A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate#1266085HAL (France)
• Editorial: Integrated PK/PD and drug metabolism approaches in drug development and evaluation.#636365NCBI PubMed Central
• Shortening Treatment by Advancing Novel Drugs#1153608ClinicalTrials.gov
• Synthetic Data in Healthcare and Drug Development: Definitions, Regulatory Frameworks, Issues#468466IRIS
• Fetal Neurobehavior in Poly-drug Dependent Women#1430242ClinicalTrials.gov
• Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam#897967ClinicalTrials.gov
• Expanding Antibiotic, Vaccine, and Diagnostics Development and Access to Tackle Antimicrobial Resistance#309784Scholarly Commons at Boston University School of Law
• Artificial intelligence in drug research and development: a review of methods and applications in drug repurposing.#218856NCBI PubMed Central
• TDCs to Treat Drug-resistant Epilepsy#1244723ClinicalTrials.gov
• Development of L-Carnitine-based New Biocompatible Ionic Liquids Aiming to Enhance Antibiotic-Coated Nano Drug Development System#264917KFUPM ePrints
• Drug response profile-based machine learning enables strategic cell line and compound selection for drug development.#266897NCBI PubMed Central
• Artificial Intelligence Across the Drug Development Lifecycle.#235891NCBI PubMed Central
• Artificial intelligence revolutionizing CNS drug discovery and development.#334803NCBI PubMed Central
• Drug Development for the Treatment of Onchocerciasis (River Blindness)#988026Iowa State University Digital Repository
• Development of Cynomolgus Monkey#1180141Springer Nature OA
• Development and Clinical Validation of a Cross-Sex Translator of ECG Drug Responses#246781HAL (France)
• A genomic-led strategy to anticipate drug safety effects#376014PLOS
• Beyond the Coca Plot: Rethinking Development Priorities and Drug Policy#483649Repositorio institucional Séneca
• Integrating chemical, genetic, and feasibility assessments for anti-tubercular target validation#657790Cornell eCommons
• Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis#1245041ClinicalTrials.gov
• SETARIA DIGITATA Novel findings of antigen protein/nucleotide and sequential anti-filarial protein/drug targets for drug development in Setaria Digitata#627354Thesis Commons
• A Kernel for Open Source Drug Discovery in Tropical Diseases#634595Duke Law Scholarship Repository
• Development of a Community-based Network for Drug Abusers#1007997ClinicalTrials.gov
• Optimizing Oligonucleotide Therapeutics: A Model-Informed Drug Development Perspective.#157920NCBI PubMed Central
• Reimagining human-centric drug development with new approach methodologies.#165619NCBI PubMed Central
• Federated Learning for Privacy-Preserving Medical Data Sharing in Drug Development#177262Semantic Scholar
• Covalent Inhibitors in Antimicrobial Drug Development-Beyond β-Lactams.#319109NCBI PubMed Central
• Aripiprazole and Lexapro Drug Interaction Study#1102972ClinicalTrials.gov
• Intercountry group meeting on the development of the mental health programme, Amman, 24-28 September 1983: WHO's response to international drug control treaties#346321WHO IRIS
• 21 U.S.C. § 357 — Qualification of drug development tools#577388US Code (LII)
• A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis#28367ClinicalTrials.gov
• Development and Investigation of the Efficacy of Lapatinib Loaded Targeted Drug Delivery Nanosystem for Breast Cancer Treatment#195240İzmir Yüksek Teknoloji Enstitüsü
• Editorial: Model-informed approaches: uniting drug development with personalized medicine.#351463NCBI PubMed Central
• Riboswitch as a drug discovery target – Current status and prospects of its development –#385103J-STAGE (Japan)
• New paradigm of q-CAR drug development targeting disease-specific protein conformations.#458633NCBI PubMed Central
• Closing the recapitulation gap in obesity-conditioned TNBC drug development.#659783NCBI PubMed Central
• An AI System for Autonomous Algorithm Evolution in Drug Development#682310bioRxiv / medRxiv